The Compounding Chemotherapy Market is becoming an important part of modern oncology services as healthcare providers seek customized medication solutions. WiseGuyReports forecasts the market to grow from USD 9.48 billion in 2024 to USD 16.5 billion by 2032, at a CAGR of 7.18%.

Manufacturers and healthcare facilities are increasingly adopting automated and robotic technologies for chemotherapy preparation. These systems can support precise dosing, improve workflow consistency, and reduce the amount of direct handling required when working with hazardous drugs.

Personalized dosage preparation is a central application, particularly when commercially available medicines do not meet a patient's specific requirements. Hospitals, oncology clinics, specialty pharmacies, and homecare providers can use compounding services for different treatment settings and patient groups.

The market is supported by strong healthcare infrastructure in North America and Europe, while Asia-Pacific offers significant expansion potential. Rising cancer-care investment and the development of specialized oncology centers are helping increase access to compounded chemotherapy across emerging markets.

Future growth areas include smart compounding equipment, centralized sterile facilities, telehealth-supported oncology services, and customized preparations for targeted therapies. Continued advances in automation and pharmacy technology could help providers deliver chemotherapy more efficiently while maintaining strict preparation and safety requirements.